Tirzepatide Offers Better A1c and Post-Meal Glucose Control

Tirzepatide was more effective than basal insulins in reducing A1c and postprandial glucose levels in a post hoc analysis.
Medscape Medical News

source https://www.medscape.com/viewarticle/tirzepatide-offers-better-glucose-control-regardless-2024a1000699?src=rss